Pfizer Limited

符号: PFIZER.BO

BSE

4108.65

INR

今天的市场价格

38.9606
市盈率
1.6870
PEG比率
187.96B
MRK市值
0.01%
DIV收益率

Pfizer Limited (PFIZER-BO) 财务报表

Q: 什么是 Pfizer Limited (PFIZER.BO) 总资产是多少？

Pfizer Limited (PFIZER.BO) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 Pfizer Limited (PFIZER.BO). 的默认数据。公司收入显示 13811.003 M 的平均值，即 0.021 % 增长率。整个期间的平均毛利润为 8632.653 M，即 0.024 %. 平均毛利率为 0.590 %. 公司去年的净收入增长率为 0.019 %，等于 0.342 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 Pfizer Limited 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 0.026. 在流动资产领域，PFIZER.BO 的报告货币为25250.9. 这些资产中的很大一部分，即 18824.7 是现金和短期投资。与去年的数据相比，该部分的变化率为0.169%. 公司的债务概况显示，以报告货币计算的长期债务总额为 933.2. 这一数字表明，-0.195% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 32073. 这方面的年同比变化率为 0.120%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为1920.7，存货估值为 4177，商誉估值为 5274.9（如有. 无形资产总额（如果有）按 442.3 估值. 应付账款和短期债务分别为 2170.6 和 411.5. 债务总额为1344.7，债务净额为 978.7. 其他流动负债为 3956.6，加上总负债 7934.3. 最后，如果存在推荐股票，则其估值为 0.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005
balance-sheet.row.cash-and-short-term-investments	75313.7	18824.7	16100.5	10980.3	21947.9	18918.1	17487.3	15230.9	10010.1	5923.2	2932.4	14285.6	8620.4	5739.9	5274	7910.1	6149.3	3069.4	2762.3	2313
balance-sheet.row.short-term-investments	112195.1	18458.7	15472.9	9410	4310	18180	16980	14555	9300	1040	0	0	0.5	0	3720.9	2479.5	1350.2	666.7	660.8	699.1
balance-sheet.row.net-receivables	3655.8	1920.7	2403.8	3082.1	3306.9	3494.6	2969.9	1535.8	1569.3	2614.8	2388.1	2055.9	2785.6	4352.8	4364.8	597.3	616.9	1361.5	835.4	724.3
balance-sheet.row.inventory	8167.8	4177	4489	4350.5	4305.9	3866.6	2970.6	3219	3606.8	3879	1515	1651.5	1832.4	1593.2	1133.7	1246.8	958.5	993.1	907.1	750.1
balance-sheet.row.other-current-assets	781.5	414.4	17.1	1491.6	618.3	662.1	508.1	185.2	100.8	89.2	24	50.9	69.6	29.2	48.2	144.9	81.7	90.3	21.4	13.7
balance-sheet.row.total-current-assets	88150.4	25250.9	23964.8	19084.8	30482.5	27153.6	24167.2	20513.1	16324.7	12506.2	6859.5	18043.9	13308	11715.1	10820.8	9899.2	7806.4	5514.3	4526.2	3801
balance-sheet.row.property-plant-equipment-net	3587.6	1854.6	2200.7	1951.4	2152.8	714.3	825.4	871.9	1016	876.5	231.8	252.1	309.9	366.5	932.8	830.6	704.1	667.6	777	756.4
balance-sheet.row.goodwill	10549.8	5274.9	5274.9	5274.9	5274.9	5274.9	5274.9	5274.9	5274.9	5274.9	-1.6	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	834.9	442.3	945.5	1448.7	1999	2549.4	3076.1	2677.5	2990.4	3417.6	1.6	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	11384.7	5717.2	6220.4	6723.6	7273.9	7824.3	8351	7952.4	8265.3	8692.5	0	0	1827.3	0	0	0	1350.2	666.7	660.8	699.1
balance-sheet.row.long-term-investments	-265.7	-399.5	285.7	618.7	628.5	641	338.6	353.9	368.4	-1040	0	0	-0.5	0	-3715.9	-2474.5	-1345.2	-666.7	-660.8	-699.1
balance-sheet.row.tax-assets	1928.9	976.7	469.8	134.6	6.2	2069.4	761.5	885.8	755.1	671.4	341.9	398.8	370.8	355.4	275	226.7	129.8	143.6	90.3	63.5
balance-sheet.row.other-non-current-assets	-24716.6	6607.4	5863.7	4145.9	3510.1	997.3	2455.9	2032.5	2151.1	3727	2333.6	1900.2	1827.4	1425.5	3720.9	2479.5	1379.5	800.1	1027.9	1299.8
balance-sheet.row.total-non-current-assets	-8081.1	14756.4	15040.3	13574.2	13571.5	12246.3	12732.4	12096.5	12555.8	12927.4	2907.3	2551.1	2507.6	2147.4	1212.9	1062.3	868.2	944.5	1234.4	1420.7
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	80069.3	40007.3	39005.1	32659	44054	39399.9	36899.6	32609.6	28880.5	25433.6	9766.8	20595	15815.6	13862.5	12033.7	10961.5	8674.6	6458.9	5760.6	5221.7
balance-sheet.row.account-payables	4513.4	2170.6	2639.4	2837.4	4267.8	4359.2	4956.3	32.3	27.7	20.1	15.2	8.6	20.9	17.4	1162.5	1072.7	924.3	1376.2	1199.8	996.1
balance-sheet.row.short-term-debt	837.8	411.5	392.5	632.3	392.5	25	25	25	21.7	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-payables	3250	1607.8	1694.6	460	460	967.1	905	896.2	839.5	700.3	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	1666.7	933.2	1277.4	426.8	886.8	0	0	25	25	25	0	0	0	0	0	0	0	0	0	120
Deferred Revenue Non Current	0	0	-102.5	0	0	0	0	-25	352.9	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	4289.8	3956.6	5482.7	4248.2	4030.2	4522.5	2766.5	6195	5570.7	5376.2	3018.6	3500.5	2489.5	1864.9	166.5	893.2	1253.1	1025.4	801.3	710.3
balance-sheet.row.total-non-current-liabilities	2551.7	1360.8	1832.1	985.2	1365.5	369.6	523.2	624.1	661.4	822.2	148.9	141.7	258.3	345.8	761.4	0	0	0	0	120
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	2454.5	1319.7	1644.9	1034.1	1254.3	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-liab	15266.4	7934.3	10361	8728.6	10099.1	9286.5	10067.6	8420.8	7245.5	6218.6	3182.7	3650.8	2768.6	2228.1	2090.4	1965.8	2177.4	2401.6	2001.1	1826.4
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.common-stock	915	457.5	457.5	457.5	457.5	457.5	457.5	457.5	457.5	457.5	298.4	298.4	298.4	298.4	298.4	298.4	298.4	298.4	298.4	288
balance-sheet.row.retained-earnings	14600.5	14600.5	11334.7	6810.3	16930.8	13080.4	9892.9	7393.4	4851.5	2489.9	3038.7	13619.7	10225.6	0	7532.9	0	4509.6	2409.7	0	0
balance-sheet.row.accumulated-other-comprehensive-income-loss	78924.6	13664.2	13664.2	13664.2	13664.2	13664.2	13664.2	13664.2	13664.2	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	35165.7	3350.8	3187.7	2998.4	2902.4	2911.3	2817.4	2673.7	2661.9	16267.6	3247	3026.1	2522.9	11336	2112	8697.2	1689.1	1349.1	3461.1	3107.3
balance-sheet.row.total-stockholders-equity	129605.8	32073	28644.1	23930.4	33954.9	30113.4	26832	24188.8	21635	19215	6584.1	16944.2	13047	11634.5	9943.3	8995.6	6497.2	4057.3	3759.5	3395.3
balance-sheet.row.total-liabilities-and-stockholders-equity	144872.2	40007.3	39005.1	32659	44054	39399.9	36899.6	32609.6	28880.5	25433.6	9766.8	20595	15815.6	13862.5	12033.7	10961.5	8674.6	6458.9	5760.6	5221.7
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	129605.8	32073	28644.1	23930.4	33954.9	30113.4	26832	24188.8	21635	19215	6584.1	16944.2	13047	11634.5	9943.3	8995.6	6497.2	4057.3	3759.5	3395.3
balance-sheet.row.total-liabilities-and-total-equity	144872.2	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	93003.4	18059.2	15787.2	10057.3	4967.1	18823.1	17318.6	14673.9	0	0	0	0	0	0	5	5	5	0	0	0
balance-sheet.row.total-debt	2504.5	1344.7	1669.9	1059.1	1279.3	25	25	25	25	25	0	0	0	0	0	0	0	0	0	120
balance-sheet.row.net-debt	39385.9	978.7	1042.3	-511.2	-16358.6	-713.1	-482.3	-650.9	-685.1	-4858.2	-2932.4	-14285.6	-8620.4	-5739.9	-5274	-5430.6	-4799.1	-3069.4	-2101.5	-1493.9

现金流量表

在 Pfizer Limited 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 -0.554 的转变。该公司最近通过发行 0 扩大了股本，与上一年相比出现了0.000 的差异. 公司的投资活动产生了现金使用净额，按报告货币计算达到-360500000.000. 与上一年相比， -0.937 发生了变化. 在同一时期，公司记录了 1055.1, 54.1 和 -352，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将-2972.1 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 -133.8，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2008	2006	2004
cash-flows.row.net-income	5021.2	8240.1	7728.9	6687.2	6424.9	6599.1	5479.1	5168.3	4704.2	2380.2	3395.8	2796.5	2779	2209.3	2106.6	4686.9	1860.1	1352.3	937.3
cash-flows.row.depreciation-and-amortization	749.4	1055.1	1150	1094.1	1032.4	713.9	662.5	629.3	579.3	1310.8	79.7	80.2	95.6	82.9	111.2	95.8	130.7	138.5	102.6
cash-flows.row.deferred-income-tax	0	-4695.3	-2304.5	-2385.9	-2527.7	-2647.4	-1957.4	-1804.3	-1762.8	0	0	0	0	0	0	0	0	0	0
cash-flows.row.stock-based-compensation	127	127	117.7	105.6	80.4	83.9	75.6	51	48	0	0	0	0	0	0	0	0	0	0
cash-flows.row.change-in-working-capital	0	-344.9	439.4	-917.8	-524.6	-2451.7	104.8	1489.1	686.1	-404.2	46.2	-29.1	-618.6	129.9	-75.3	-333.9	116.4	-24.1	79.8
cash-flows.row.account-receivables	0	-102	-189.1	428.6	-24.6	-192.4	-452.6	182.4	124.1	0	0	0	0	0	0	0	0	0	0
cash-flows.row.inventory	0	218.5	-138.6	-44.6	-439.3	-908.2	248.4	387.8	272.2	-788.2	136.5	-143.3	-239.1	116.2	-296.2	34.6	-86	-157	244.2
cash-flows.row.account-payables	0	-381.1	-111.9	-1409.3	32.2	-591	1099.9	608.9	56.9	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-working-capital	0	-80.3	879	107.5	-92.9	-760.1	-790.9	310	232.9	384.1	-90.3	114.2	-379.4	13.8	220.9	-368.5	202.4	132.9	-164.4
cash-flows.row.other-non-cash-items	-5148.2	-825.2	-460.7	-309.9	-1253.6	-1319.7	-1046.6	-4049.5	-2562.9	-2152	-2197.3	-3007.7	-2011.5	-1675.3	230.4	-4282.6	-875.4	-439.3	-247.5
cash-flows.row.net-cash-provided-by-operating-activities	5021.2	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	0	-649.8	-153.1	-177	-168.9	-44.9	-1026.9	-252.9	-436.7	-205.7	-42.2	-6.7	-33.2	-187.1	-266.8	-136.7	-229.3	-149.2	-52.7
cash-flows.row.acquisitions-net	0	1804.8	20.6	0.8	2.3	1.4	65.9	359.2	2.3	0	0	4559.3	-0.5	0	0	0	0	0	0
cash-flows.row.purchases-of-investments	0	-2292.9	-6125	-5019.9	-12079.6	-1194	-2656.2	-5020	-8326.8	-1209.7	0	759.6	1991.6	-910	-1075	-670	0	-650	-675
cash-flows.row.sales-maturities-of-investments	0	723.3	437.7	443.2	13842.7	2712.9	3624.7	7086.6	564.3	0	0	872.4	1992.6	0	0	0	0	0	0
cash-flows.row.other-investing-activites	0	54.1	69.6	64.5	13706.7	-1124.2	-2390.6	2417.3	1752.5	527.6	1068.9	833.6	-2350.7	621.6	553	3130.2	303.9	68.4	42.8
cash-flows.row.net-cash-used-for-investing-activites	0	-360.5	-5750.2	-4688.4	15303.2	351.2	-2383.1	-2496.4	-7008.7	-887.7	1026.6	6258.7	2775.2	-475.5	-788.7	2323.5	74.6	-730.8	-685
cash-flows.row.debt-repayment	0	-352	-98.9	-490.9	-390	0	0	0	0	0	0	0	0	0	0	0	0	-120	0
cash-flows.row.common-stock-issued	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.common-stock-repurchased	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	-2972.1	-1597.4	-15193.5	-1029.3	-910.5	-917.3	-686.2	-502.4	-13.8	-11611.1	-206.6	-141.3	-433.2	-952	-758.8	-337.5	-336.8	-247.3
cash-flows.row.other-financing-activites	0	-133.8	-108.8	-26.3	-215.9	-188	-186.2	-139.7	-116.4	0	-1990.6	-225.4	0	0	0	-0.2	-0.7	-3.4	100.1
cash-flows.row.net-cash-used-provided-by-financing-activities	0	-3457.9	-1805.1	-15710.7	-1635.2	-1098.5	-1103.5	-825.9	-618.8	-13.8	-13601.7	-432	-141.3	-433.2	-952	-759	-338.2	-460.2	-147.1
cash-flows.row.effect-of-forex-changes-on-cash	0	0	0	0	0	0	0	-0.5	-0.8	0	0	0	0	5.9	0	0	0	0	0
cash-flows.row.net-change-in-cash	-14436.4	-261.6	-884.5	-16125.8	16899.8	230.8	-168.6	-34.6	-4173.5	1805.4	-11250.6	5666.6	2878.5	-156.1	632.3	1730.9	968.3	-163.6	44.7
cash-flows.row.cash-at-end-of-period	21692.7	366	627.6	1512.1	17637.9	738.1	507.3	675.9	710.5	4884	3078.6	14329.2	8662.6	5274	5430.2	4799.1	3068.3	100	263.6
cash-flows.row.cash-at-beginning-of-period	36129.1	627.6	1512.1	17637.9	738.1	507.3	675.9	710.5	4884	3078.6	14329.2	8662.6	5784.2	5430.2	4797.9	3068.3	2100	263.6	218.9
cash-flows.row.operating-cash-flow	5021.2	3556.8	6670.8	4273.3	3231.8	978.1	3318	3288.2	3454.8	1134.7	1324.5	-160.1	244.6	746.7	2373	166.3	1231.9	1027.4	872.1
cash-flows.row.capital-expenditure	0	-649.8	-153.1	-177	-168.9	-44.9	-1026.9	-252.9	-436.7	-205.7	-42.2	-6.7	-33.2	-187.1	-266.8	-136.7	-229.3	-149.2	-52.7
cash-flows.row.free-cash-flow	5021.2	2907	6517.7	4096.3	3062.9	933.2	2291.1	3035.3	3018.1	929.1	1282.2	-166.8	211.4	559.6	2106.2	29.6	1002.5	878.2	819.4

利润表行

Pfizer Limited 的收入与上期相比变化了 -0.071%。据报告, PFIZER.BO 的毛利润为 15510.9。该公司的营业费用为 8477.4，与上年相比变化了 -10.028%. 折旧和摊销费用为 1055.1，与上一会计期间相比变化了 -0.083%. 营业费用报告为 8477.4，显示-10.028% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.022%. 营业收入为 7236.1，与上年相比变化了-0.022%. 净利润的变化率为 0.019%。去年的净收入为6239.3.

common:word.in-mln USD Growth	TTM	2021	2019	2017	2015	2013	2011	2009	2007	2005
income-statement-row.row.total-revenue	22191.8	24247.6	26109.9	22384.3	21515.1	20814.2	19684.7	19661.8	20122.7	18277.4	10042.7	9479.8	10173.2	0	7722.7	6777.1	6766.9	6667.9	6030.3	5930.6
income-statement-row.row.cost-of-revenue	8192.4	8736.7	9480.3	7977.4	7924	7479	7396.8	7964.8	7874.2	7403.4	3752.7	3334.9	3595.3	0	2954.6	2682.6	2631.7	2267.5	2357.2	2575.6
income-statement-row.row.gross-profit	13999.4	15510.9	16629.6	14406.9	13591.1	13335.2	12287.9	11697	12248.5	10874.1	6290	6144.9	6578	0	4768.1	4094.5	4135.3	4400.4	3673.1	3355
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	478.6	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	615.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	1367.6	1010.5	626.5	358.8	195	107.9	88.9	82.5	192.3	193.8	215.3	144.5	132.6	0	198.3	2079.1	-173.5	-233.7	-233.7	-192.2
income-statement-row.row.operating-expenses	8471.4	8477.4	9422.3	8371.8	8840.7	8368.3	7940.5	8825	8477.7	8310.4	3968.6	4378.2	4703.9	0	3160.2	1987.9	-551.8	2943	2319.2	2484.4
income-statement-row.row.cost-and-expenses	16663.8	17214.1	18902.6	16349.2	16764.7	15847.3	15337.3	16789.8	16352	15713.8	7721.3	7713	8299.2	0	6114.8	4670.5	2079.8	5210.5	4676.4	5060
income-statement-row.row.interest-income	914.2	854.9	489.4	387.4	1295.4	1255.8	982.7	877	575.9	445.4	857.4	891.2	786.3	0	522.6	0	582.5	403.4	83.2	74.8
income-statement-row.row.interest-expense	109.9	133.9	104.9	151.1	108.5	12.9	4.2	9.6	5.2	7.7	3.6	2.4	5.9	0	0	0	0.2	0.7	0	0
income-statement-row.row.selling-and-marketing-expenses	615.9	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	1141.3	149.1	-162.4	203.5	260.5	257.7	52.9	1405.4	339.4	-800.7	17.5	4143.5	-4.4	0	261.9	2079.1	-173.7	-234.4	-235.3	-125.5
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	1367.6	1010.5	626.5	358.8	195	107.9	88.9	82.5	192.3	193.8	215.3	144.5	132.6	0	198.3	2079.1	-173.5	-233.7	-233.7	-192.2
income-statement-row.row.total-operating-expenses	1141.3	149.1	-162.4	203.5	260.5	257.7	52.9	1405.4	339.4	-800.7	17.5	4143.5	-4.4	0	261.9	2079.1	-173.7	-234.4	-235.3	-125.5
income-statement-row.row.interest-expense	109.9	133.9	104.9	151.1	108.5	12.9	4.2	9.6	5.2	7.7	3.6	2.4	5.9	0	0	0	0.2	0.7	0	0
income-statement-row.row.depreciation-and-amortization	749.4	1055.1	1150	1094.1	1032.4	713.9	662.5	629.3	579.3	1310.8	79.7	80.2	95.6	0	82.9	111.2	95.8	130.7	138.5	102.6
income-statement-row.row.ebitda-caps	7645	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	5528	7236.1	7401.9	6096.3	4869	5085.6	4443.5	2885.9	3789	3180.8	3378.3	2794.2	2779.6	0	1838.2	2106.6	4687.1	1860.8	1353.9	870.6
income-statement-row.row.income-before-tax	6669.3	8240.1	7728.9	6687.2	6424.9	6599.1	5479.1	5168.3	4704.2	2380.2	3395.8	6937.7	2775.3	0	2100.1	4185.6	4513.4	1626.5	1118.6	745.1
income-statement-row.row.income-tax-expense	1648.1	2000.8	1603.3	1711.1	1333.6	2308.6	1878.4	1800.5	1654.4	1376.8	1187.3	1905.7	929.2	0	731.3	1194.4	1113.4	563.1	411.3	299.2
income-statement-row.row.net-income	5021.2	6239.3	6125.6	4976.1	5091.3	4290.5	3600.7	3367.8	3049.8	698.2	2208.6	5032	1694.4	0	1368.8	2991.2	3400	1063.3	707.3	445.9